Search research articles
Contact Us
Filters
Showing results (41-50 of 73) with videos related to
Page
of 8
Sort By:
Journal of Cancer Research and Clinical Oncology
|
January 1, 1989
Phase-I trial of intravenous continuous infusion of tumor necrosis factor in advanced metastatic carcinomas
B Wiedenmann, P Reichardt, U Räth, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 24, 2006
Clinico-histologic parameters of osteosarcoma patients with late relapse
E I Hauben, S Bielack, R Grimer, et al.
Acta Radiologica (Stockholm, Sweden : 1987)
|
October 15, 2013
Differentiation of myxoid liposarcoma by magnetic resonance imaging: a histopathologic correlation
D Löwenthal, M Zeile, M Niederhagen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 29, 2010
A phase I-II study of everolimus (RAD001) in combination with imatinib in patients with imatinib-resistant gastrointestinal stromal tumors
P Schöffski, P Reichardt, J-Y Blay, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 8, 2006
Phase 1 European Organisation for Research and Treatment of Cancer study determining safety of pegylated liposomal doxorubicin (Caelyx) in combination with ifosfamide in previously untreated adult patients with advanced or metastatic soft tissue sarcomas
O S Nielsen, P Reichardt, T B Christensen, et al.
British Journal of Cancer
|
July 28, 2011
Docetaxel and capecitabine for advanced gastric cancer: investigating dose-dependent efficacy in two patient cohorts
P C Thuss-Patience, A Kretzschmar, Y Dogan, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 6, 2008
Paclitaxel in patients with advanced angiosarcomas of soft tissue: a retrospective study of the EORTC soft tissue and bone sarcoma group
M Schlemmer, P Reichardt, J Verweij, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 24, 2012
Phase III study of nilotinib versus best supportive care with or without a TKI in patients with gastrointestinal stromal tumors resistant to or intolerant of imatinib and sunitinib
P Reichardt, J-Y Blay, H Gelderblom, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 25, 2013
Osteosarcoma of the mobile spine
K Zils, S Bielack, M Wilhelm, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 6, 2007
Exatecan in pretreated adult patients with advanced soft tissue sarcoma: results of a phase II--study of the EORTC Soft Tissue and Bone Sarcoma Group
P Reichardt, O S Nielsen, S Bauer, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 73) with videos related to
Sort By:
Page
of 8
Journal of Cancer Research and Clinical Oncology
|
January 1, 1989
Phase-I trial of intravenous continuous infusion of tumor necrosis factor in advanced metastatic carcinomas
B Wiedenmann, P Reichardt, U Räth, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 24, 2006
Clinico-histologic parameters of osteosarcoma patients with late relapse
E I Hauben, S Bielack, R Grimer, et al.
Acta Radiologica (Stockholm, Sweden : 1987)
|
October 15, 2013
Differentiation of myxoid liposarcoma by magnetic resonance imaging: a histopathologic correlation
D Löwenthal, M Zeile, M Niederhagen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 29, 2010
A phase I-II study of everolimus (RAD001) in combination with imatinib in patients with imatinib-resistant gastrointestinal stromal tumors
P Schöffski, P Reichardt, J-Y Blay, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 8, 2006
Phase 1 European Organisation for Research and Treatment of Cancer study determining safety of pegylated liposomal doxorubicin (Caelyx) in combination with ifosfamide in previously untreated adult patients with advanced or metastatic soft tissue sarcomas
O S Nielsen, P Reichardt, T B Christensen, et al.
British Journal of Cancer
|
July 28, 2011
Docetaxel and capecitabine for advanced gastric cancer: investigating dose-dependent efficacy in two patient cohorts
P C Thuss-Patience, A Kretzschmar, Y Dogan, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 6, 2008
Paclitaxel in patients with advanced angiosarcomas of soft tissue: a retrospective study of the EORTC soft tissue and bone sarcoma group
M Schlemmer, P Reichardt, J Verweij, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 24, 2012
Phase III study of nilotinib versus best supportive care with or without a TKI in patients with gastrointestinal stromal tumors resistant to or intolerant of imatinib and sunitinib
P Reichardt, J-Y Blay, H Gelderblom, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 25, 2013
Osteosarcoma of the mobile spine
K Zils, S Bielack, M Wilhelm, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 6, 2007
Exatecan in pretreated adult patients with advanced soft tissue sarcoma: results of a phase II--study of the EORTC Soft Tissue and Bone Sarcoma Group
P Reichardt, O S Nielsen, S Bauer, et al.
Page
of 8